Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma. A Randomized Clinical Trial
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Complication rate
研究概览
简要总结
Introduction: Surgery is the only potential curative approach for the highly lethal gallbladder carcinoma. The laparoscopic surgery has developed rapidly since invented. As a kind of minimally invasive surgery, laparoscopic cholecystectomy including segmentg IVB and V is preferred by most of surgeons. There have been studies comparing intraoperative blood loss, postoperative morbidity, length of hospital stay and costs of laparoscopic cholecystectomy over open surgery. However, randomized controlled trials are still lacking but clearly required to reveal whether the laparoscopic approach or the open surgery is the better option for treating gallbladder carcinoma. We hypothesize that incidence of postoperative complications is lower, and time to functional recovery is shorter after laparosopic compared with open approach, even in an enhanced recovery setting.
Methods/design: We designed this prospective, randomized, controlled trial with two treatment approaches, laparoscopic versus open surgery for gallbladder carcinoma. The trial hypothesis is that laparoscopic approach has advantages in postoperative recoveries and be equivalent in operation time, oncological results and long-term follow-up compared with open counterpart. The duration of the entire trial is four years including prearrangement, follow-up and analyses.
Discussion: Although several studies have discussed different surgical approaches for gallbladder carcinoma treatment, this trial will be a thorough RCT comparing laparoscopic and open surgery for gallbladder carcinoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically proven gallbladder carcinoma.
- •Highly presumed malignancy with difficulties to obtain histological evidence.
- •Preoperative staging work up performed by upper abdomen enhanced CT scan and showed no vessel involvment.
- •The subject understands the nature of this trial and willing to comply.
- •Ability to provide written informed consent.
- •Patients treated with curative intent in accordance to international guidelines.
排除标准
- •Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, involvement of other organs.
- •Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score >
- •Synchronous malignancy in other organs.
- •Palliative surgery.
研究组 & 干预措施
3D approach
Three dimensional laparoscopic cholecystectomy including segments IVB and V
干预措施: Three dimensional laparoscopic (Procedure)
open approach
Open cholecystectomy including segments IVB and V
干预措施: Open (Procedure)
结局指标
主要结局
Complication rate
时间窗: 24 months
Complication rate is defined as the number of subjects developed complication divided the total subjects number
R0 rescetion rate
时间窗: 24 months
R0 rescetion rate for the carcinoma
Length of stay
时间窗: 24 months
LOS is defined as the days between the surgery and hospital discharged
Operation time
时间窗: 24 months
Operation time is definied as the from either skin incision or trocar placement to the entire skin closure.
Estimated blood loss
时间窗: 24 months
EBL is defined as the blood loss during the surgical procedure
Intraoperative blood transfusion
时间窗: 24 months
IBT is defined as whether the subjects receive blood transfusion during the surgical procedure
次要结局
未报告次要终点
